DE69010162D1 - Zusammensetzung zur Behandlung von Entzündung. - Google Patents

Zusammensetzung zur Behandlung von Entzündung.

Info

Publication number
DE69010162D1
DE69010162D1 DE69010162T DE69010162T DE69010162D1 DE 69010162 D1 DE69010162 D1 DE 69010162D1 DE 69010162 T DE69010162 T DE 69010162T DE 69010162 T DE69010162 T DE 69010162T DE 69010162 D1 DE69010162 D1 DE 69010162D1
Authority
DE
Germany
Prior art keywords
inflammation
treatment
composition
antichymotrypsin
fowl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69010162T
Other languages
English (en)
Other versions
DE69010162T2 (de
Inventor
John Lezdey
Allan Wachter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69010162D1 publication Critical patent/DE69010162D1/de
Publication of DE69010162T2 publication Critical patent/DE69010162T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69010162T 1989-12-04 1990-08-29 Zusammensetzung zur Behandlung von Entzündung. Expired - Fee Related DE69010162T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/445,005 US5008242A (en) 1986-12-24 1989-12-04 Treatment of inflammation using 1-antichymotrypsin

Publications (2)

Publication Number Publication Date
DE69010162D1 true DE69010162D1 (de) 1994-07-28
DE69010162T2 DE69010162T2 (de) 1994-10-06

Family

ID=23767272

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69010162T Expired - Fee Related DE69010162T2 (de) 1989-12-04 1990-08-29 Zusammensetzung zur Behandlung von Entzündung.

Country Status (8)

Country Link
US (1) US5008242A (de)
EP (1) EP0432117B1 (de)
JP (1) JPH03181422A (de)
AT (1) ATE107515T1 (de)
CA (1) CA2019974C (de)
DE (1) DE69010162T2 (de)
DK (1) DK0432117T3 (de)
ES (1) ES2055406T3 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114917A (en) * 1986-12-24 1992-05-19 John Lezdey Treatment of inflammation using alpha 1-antichymotrypsin
US5217951A (en) * 1986-12-24 1993-06-08 John Lezdey Treatment of inflammation
US5166134A (en) * 1986-12-24 1992-11-24 John Lezdey Treatment of allergic rhinitis
US5723316A (en) * 1989-06-23 1998-03-03 Trustees Of The University Of Pennsylvania α-1-antichymotrypsin analogues having chymase inhibiting activity
US5674708A (en) * 1989-06-23 1997-10-07 Trustees Of The University Of Pennsylvania α-1-antichymotrypsin analogues having elastase inhibitory activity
ES2096665T3 (es) * 1990-10-16 1997-03-16 John Lezdey Tratamiento de la inflamacion.
JPH067191A (ja) * 1991-09-26 1994-01-18 Konica Corp モノクローナル抗体、それを産生するハイブリド−マ、その対応抗原及びそれを用いた測定方法
US5422244A (en) * 1992-05-05 1995-06-06 Athena Neurosciences, Inc. Detection of brain α1-antichymotrypsin
US5346886A (en) * 1993-11-15 1994-09-13 John Lezdey Topical α-1-antitrypsin, non-aqueous lipid miscible, benzalkonium chloride compositions for treating skin
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
EP0898962A1 (de) * 1997-08-28 1999-03-03 Becton, Dickinson and Company Transdermale Pflaster und Verfahren zur Inaktivierung von Hautproteasen
US6849605B1 (en) * 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
US7247704B2 (en) * 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
EP1568376B1 (de) * 2001-04-30 2012-11-21 Bayer Innovation GmbH Verwendung von alpha-1 Antichymotrypsin zur Herstellung einer Zusammensetzung zur Behandlung, Vorbeugung oder Diagnose von schwerheilenden diabetischen oder arteriellen Wunden
DE10121255A1 (de) 2001-04-30 2002-11-07 Switch Biotech Ag Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
AU2003296378A1 (en) * 2002-12-06 2004-06-30 Arriva Pharmaceuticals, Inc. Methods and compositions for treatment of otitis media
US20050031652A1 (en) * 2003-02-25 2005-02-10 Allergan, Inc. Compositions and methods comprising memantine and polyanionic polymers
US7850970B2 (en) 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
US7217690B2 (en) 2003-10-07 2007-05-15 Kimberly-Clark Worldwide, Inc. Compositions of sunflower trypsin inhibitors
EP1737499A4 (de) * 2004-03-09 2009-07-22 Arriva Pharmaceuticals Inc Behandlung von chronisch obstruktiver lungenerkrankung durch inhalation von niedrigen dosen eines proteasehemmers
WO2010025314A2 (en) * 2008-08-28 2010-03-04 The General Hospital Corporation Prevention and treatment of itch with cysteine protease inhibition
WO2012178102A2 (en) 2011-06-24 2012-12-27 The Regents Of The Unversity Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
JP2015504675A (ja) 2012-01-10 2015-02-16 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイトＴＨＥ ＲＥＧＥＮＴＳ ＯＦ ＴＨＥ ＵＮＩＶＥＲＳＩＴＹ ＯＦ ＣＯＬＯＲＡＤＯ，ａ ｂｏｄｙ ｃｏｒｐｏｒａｔｅ アルファ−１アンチトリプシン融合分子の組成物、方法、及び使用
US10426815B2 (en) 2015-01-20 2019-10-01 The General Hospital Corporation Prevention and treatment of itch with an MRGPR antagonist
JPWO2021020509A1 (de) * 2019-07-31 2021-02-04

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117113A (en) * 1974-06-25 1978-09-26 National Research Development Corporation Immunological preparations
FR2374910A1 (fr) * 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
US4829052A (en) * 1986-06-11 1989-05-09 Monsanto Company Serine protease inhibitors
US4916117A (en) * 1986-12-24 1990-04-10 John Lezdey Treatment of inflammation using alpha 1-antichymotrypsin

Also Published As

Publication number Publication date
JPH03181422A (ja) 1991-08-07
ATE107515T1 (de) 1994-07-15
EP0432117B1 (de) 1994-06-22
DE69010162T2 (de) 1994-10-06
US5008242A (en) 1991-04-16
CA2019974C (en) 2002-01-22
CA2019974A1 (en) 1991-06-04
DK0432117T3 (da) 1994-07-25
ES2055406T3 (es) 1994-08-16
EP0432117A1 (de) 1991-06-12

Similar Documents

Publication Publication Date Title
DE69010162D1 (de) Zusammensetzung zur Behandlung von Entzündung.
PT93333A (pt) Processo de preparacao de uma composicao biocida sinergica e de tratamento usando a referida composicao
DE68907909T2 (de) Präparat zur behandlung von erektionsstörungen.
DE69019716T2 (de) Medizinisches Gerät zur Laserbehandlung.
DE3884622D1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
ATE96313T1 (de) Fettsaeure-zusammensetzungen.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
DE69013999D1 (de) Siliconkautschukzusammensetzung zur Behandlung von Faserstrukturen.
DE69200684T2 (de) Vorrichtung zur thermischen Behandlung von laufenden Garnen.
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
DE3782214D1 (de) Mittel zur behandlung des scheidenmilieus.
DE3681642D1 (de) Benzopyran-verbindungen zur behandlung von inkontinenz.
DE69301750T2 (de) Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
DE69023459T2 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
ATE128871T1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
DE68913995T2 (de) Zusammensetzung zur behandlung progressiver myopie.
AT400095B (de) Zahnärztliches handstück für die behandlung von zähnen mit laserstrahlen
DE69000960T2 (de) Zusammensetzung zur behandlung von pigmentierung.
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
DE69002821D1 (de) Zusammensetzung zur haarbehandlung.
DE3583337D1 (de) Zusammensetzung zur behandlung von haemorroiden.
IT8722869V0 (it) Dispositivo perfezionato per l'abbronzatura artificiale integrale o parziale.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee